IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria.

Gestational diabetes mellitus International Diabetes Federation Diabetes Atlas Prevalence Regional differences

Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 08 08 2021
accepted: 19 08 2021
pubmed: 10 12 2021
medline: 9 2 2022
entrez: 9 12 2021
Statut: ppublish

Résumé

The approaches used to screen and diagnose gestational diabetes mellitus (GDM) vary widely. We generated a comparable estimate of the global and regional prevalence of GDM by International Association of Diabetes in Pregnancy Study Group (IADPSG)'s criteria. We searched PubMed and other databases and retrieved 57 studies to estimate the prevalence of GDM. Prevalence rate ratios of different diagnostic criteria, screening strategies and age groups, were used to standardize the prevalence of GDM in individual studies included in the analysis. Fixed effects meta-analysis was conducted to estimate standardized pooled prevalence of GDM by IDF regions and World Bank country income groups. The pooled global standardized prevalence of GDM was 14.0% (95% confidence interval: 13.97-14.04%). The regional standardized prevalence of GDM were 7.1% (7.0-7.2%) in North America and Caribbean (NAC), 7.8% (7.2-8.4%) in Europe (EUR), 10.4% (10.1-10.7%) in South America and Central America (SACA), 14.2% (14.0-14.4%) in Africa (AFR), 14.7% (14.7-14.8%) in Western Pacific (WP), 20.8% (20.2-21.4%) in South-East Asia (SEA) and 27.6% (26.9-28.4%) in Middle East and North Africa (MENA). The standardized prevalence of GDM in low-, middle- and high-income countries were 12.7% (11.0-14.6%), 9.2% (9.0-9.3%) and 14.2% (14.1-14.2%), respectively. The highest standardized prevalence of GDM was in MENA and SEA, followed by WP and AFR. Among the three World Bank country income groups, high income countries had the highest standardized prevalence of GDM. The standardized estimates for the prevalence of GDM provide an insight for the global picture of GDM.

Identifiants

pubmed: 34883186
pii: S0168-8227(21)00409-5
doi: 10.1016/j.diabres.2021.109050
pii:
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

109050

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hui Wang (H)

Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University and Tianjin Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.

Ninghua Li (N)

Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University and Tianjin Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.

Tawanda Chivese (T)

Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.

Mahmoud Werfalli (M)

Department of Family and Community Medicine, Faculty of Medicine, University of Benghazi, Benghazi, Libya.

Hong Sun (H)

International Diabetes Federation, Brussels, Belgium.

Lili Yuen (L)

School of Medicine, Western Sydney University, Campbelltown, Australia.

Cecilia Ambrosius Hoegfeldt (CA)

Department of Psychiatry, University of Oxford, Oxford, UK.

Camille Elise Powe (C)

Diabetes Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, USA.

Jincy Immanuel (J)

School of Medicine, Western Sydney University, Campbelltown, Australia.

Suvi Karuranga (S)

International Diabetes Federation, Brussels, Belgium.

Hema Divakar (H)

Divakars Specialty Hospital, Bangalore, India.

NAomi Levitt (N)

Chronic Disease Initiative for Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa; Division of Endocrinology, Department of Medicine, University of Cape Town, Cape Town, Western Cape, South Africa.

Changping Li (C)

Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University and Tianjin Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.

David Simmons (D)

Department of Psychiatry, University of Oxford, Oxford, UK.

Xilin Yang (X)

Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University and Tianjin Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China. Electronic address: yangxilin@tmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH